The effects of these pro-inflammatory cytokines are highly relevant in the context of MS as recent studies have shown that TNF, IFNγ, and LTα levels are increased in the CSF of progressive MS patients and correlated with meningeal inflammation, cortical demyelination, and activation of MHCII+ microglia [58,59]. The gene discussed is LTA; the disease is myeloid sarcoma.